1. Home
  2. TGT vs IQV Comparison

TGT vs IQV Comparison

Compare TGT & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Corporation

TGT

Target Corporation

HOLD

Current Price

$96.96

Market Cap

41.7B

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$225.10

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGT
IQV
Founded
1902
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.7B
36.4B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
TGT
IQV
Price
$96.96
$225.10
Analyst Decision
Hold
Buy
Analyst Count
27
17
Target Price
$101.04
$237.59
AVG Volume (30 Days)
7.9M
1.4M
Earning Date
11-19-2025
10-28-2025
Dividend Yield
4.70%
N/A
EPS Growth
N/A
N/A
EPS
8.25
7.30
Revenue
$105,242,000,000.00
$15,904,000,000.00
Revenue This Year
N/A
$6.14
Revenue Next Year
$1.77
$5.35
P/E Ratio
$11.75
$30.94
Revenue Growth
N/A
3.85
52 Week Low
$83.44
$134.65
52 Week High
$145.08
$234.30

Technical Indicators

Market Signals
Indicator
TGT
IQV
Relative Strength Index (RSI) 66.12 55.28
Support Level $90.17 $217.86
Resistance Level $92.91 $230.80
Average True Range (ATR) 2.60 5.52
MACD 0.88 -1.08
Stochastic Oscillator 98.15 53.14

Price Performance

Historical Comparison
TGT
IQV

About TGT Target Corporation

Target's start dates back to 1962, but now it is one of the largest discount retailers in the United States (where it derives all of its sales), operating just under 2,000 stores and generating over $106 billion in fiscal 2024 sales. The company offers a broad assortment of merchandise across categories including apparel and accessories (16% of fiscal 2024 revenue), beauty and household essentials (30%), food and beverage (23%), hardlines (15%), as well as home furnishings (16%). Target's model is anchored in its physical store base, which fulfills more than 97% of sales. Around 30% of sales are derived from its own private-label brands.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: